EUVIMEDEUVIMED entdecken
Crossref

N1F(Improved-Nephropathy 1 Formula) Ameliorates Renal Interstitial Fibrosis via Inhibiting Extracellular Matrix Deposition and Regulating the FGF23/P38MAPK/Wnt Pathway

Wenxiu Yu, Congcong Zeng, Chenggong Wang, Sining Jia, Chen Liu, Yini Zeng, Jinguo Cheng

Cell Biochemistry and Biophysics · 2024

DOI: 10.1007/s12013-024-01244-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Wenxiu Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, PR China. Hauptthemen laut MEDLINE: Extracellular Matrix, Fibrosis, Kidney, p38 Mitogen-Activated Protein Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Zhejiang Provincial Science and Technology Department Project, Zhejiang Provincial Administration of Traditional Chinese Medicine Co-construction of Science and Technology Program Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Renal fibrosis is the primary pathway in the progression of chronic kidney disease (CKD) towards end-stage renal failure. The currently used drugs currently are ineffective, and their mechanisms of action remain unclear. This study aims to investigate the nephroprotective effect of Improved-Nephropathy 1 Formula (N1F) in a rat model of unilateral ureteral obstruction (UUO) and explore the potential mechanisms of N1F-containing serum in treating TGF-ß1-induced human renal tubular epithelial cells (HK-2). METHODS: SD rats received 2-week continuous N1F gavage starting on day 2 after UUO. HK-2 cells were pretreated with a P38MAPK inhibitor for 1 h in vitro, followed by induction of the cells with TGF-ß1 and treatment with N1F 48 h later. The chemical composition of N1F was analyzed using high-performance liquid chromatography-Q-Orbitrap high-resolution liquid mass spectrometry. Renal function was assessed by measuring serum creatinine (Scr), blood urea nitrogen (BUN) and urine protein (Upro) levels. Hematoxylin and eosin (HE) and Masson's trichrome (Masson) staining were used to evaluate the extent of renal tissue damage and fibrosis. Western blotting, immunohistochemistry, and immunofluorescence were used to detect the protein levels of relevant indices. The RNA levels of the relevant indices were detected using real-time fluorescence quantitative PCR (RT-qPCR). RESULTS: We identified 361 chemical components in the water extract of N1F. These chemical components of N1F significantly reduced the area associated with interstitial fibrosis in the kidneys of UUO rats and the levels of serum creatinine, urea nitrogen, and urinary protein. Additionally, N1F decreased the protein levels of FGF23, Wnt1, ß-catenin and p-P38MAPK/P38MAPK, along with the expression of renalfibrosis-associated proteins, α-SMA, FN, Collagen III, and Vimentin in the renal tissues of the UUO rats, while enhancing klotho and DKK1 protein levels. In vitro experiments revealed that inhibition of P38MAPK signaling significantly suppressed the expression of proteins related to the Wnt signaling pathway, with a concomitant decrease in the expression of FGF23 and an increase in the expression of Klotho. Notably, the P38MAPK inhibitor (SB203580) had similar effects to N1F in altering the above-mentioned indices in vitro. CONCLUSIONS: N1F may exhibit potential therapeutic efficacy against renal fibrosis by inhibiting the FGF23/P38MAPK/Wnt signaling pathway, consequently inhibiting extracellular matrix deposition due to renal injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular MatrixFibrosisKidneyp38 Mitogen-Activated Protein KinasesUreteral ObstructionAnimalsHumansMaleRatsCell LineDisease Models, AnimalFibroblast Growth FactorsKidney DiseasesRats, Sprague-DawleyTransforming Growth Factor beta1Wnt Signaling Pathway

Stichwörter der Autor:innen

Chronic kidney diseaseFGF23/P38MAPK/Wnt pathwayImproved-Nephropathy 1 Formula(N1F)Renal fibrosisTraditional Chinese medicine(TCM)

Substanzen

Fibroblast Growth Factorsp38 Mitogen-Activated Protein KinasesTransforming Growth Factor beta1

Autor:innen und Institutionen

  • The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, PR China.
  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, PR China.
  • School of Pharmacy, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, PR China.
  • Zhejiang Chinese Medical University, Hangzhou, 310026, Zhejiang, PR China.
  • The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang, PR China. wzchengjinguo@126.co.

Förderung

  • Zhejiang Provincial Science and Technology Department Project
  • Zhejiang Provincial Administration of Traditional Chinese Medicine Co-construction of Science and Technology Program Project

Zitieren

APA

Yu, W., Zeng, C., Wang, C., Jia, S., Liu, C., Zeng, Y., & Cheng, J. (2024). N1F(Improved-Nephropathy 1 Formula) Ameliorates Renal Interstitial Fibrosis via Inhibiting Extracellular Matrix Deposition and Regulating the FGF23/P38MAPK/Wnt Pathway. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01244-6

Vancouver

Yu W, Zeng C, Wang C, Jia S, Liu C, Zeng Y, et al. N1F(Improved-Nephropathy 1 Formula) Ameliorates Renal Interstitial Fibrosis via Inhibiting Extracellular Matrix Deposition and Regulating the FGF23/P38MAPK/Wnt Pathway. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01244-6

BibTeX
@article{Yu2024,
  author = {Yu, Wenxiu and Zeng, Congcong and Wang, Chenggong and Jia, Sining and Liu, Chen and Zeng, Yini and Cheng, Jinguo},
  title = {N1F(Improved-Nephropathy 1 Formula) Ameliorates Renal Interstitial Fibrosis via Inhibiting Extracellular Matrix Deposition and Regulating the FGF23/P38MAPK/Wnt Pathway},
  journal = {Cell Biochemistry and Biophysics},
  year = {2024},
  doi = {10.1007/s12013-024-01244-6}
}
Kostenlos starten →